CLSL
Crop Life Science financials
- Market cap
- ₹142 Cr
- Sector
- Chemicals
What Crop Life Science Limited does
Crop Life Science Limited manufactures crop-protection and plant-nutrition products — insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators and soil/plant health solutions — from its ISO 9001:2015 and ISO 14001:2015 certified manufacturing unit in Ankleshwar, Gujarat. It sells branded formulations such as Libra, Armeezin and Suforty-90 through a domestic network covering seven states and exports to markets including Egypt, Saudi Arabia, Indonesia, Vietnam, UAE and China. The company runs a Biological Research and Development Laboratory at Ankleshwar and has a subsidiary, Hetban Spechem Limited.
Segments
- Technical
- Formulation
- Fertilizers
- Plant Growth Regulators
- Organic Products
- Formulation Brand
- Manufacturing units
- 1 (Ankleshwar, Gujarat)
- Domestic market presence
- 7 states (Gujarat, Madhya Pradesh, Maharashtra, Chhattisgarh, Uttar Pradesh, West Bengal, Bihar)
- Export countries
- 12 (Egypt, Saudi Arabia, Ethiopia, Gabon, Indonesia, Morocco, Nepal, Bangladesh, Vietnam, Sudan, UAE, China)
- Product categories
- Insecticides, Fungicides, Herbicides, Micro fertilizers, Bio-Pesticides, Bio-Fertilizers, Plant Growth Regulators, Soil/plant health solutions
- Best-selling product brands (FY24-25)
- 10 (Libra, Armeezin, Suforty-90, Dadubar, Ambucrop, Bio-Shakti, Qvidic, Seapen, P-Dozer, Rustblast)
- R&D facility
- Biological Research and Development Laboratory, Ankleshwar (inaugurated FY2021-22)
Quarterly results
Q4 FY26: revenue down 10.3%, net profit up 33.3% against the same quarter last year.
| Line item | Q2 FY24 | Q2 FY25 | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|---|---|
| Revenue | 97 | 106 | 94 | 120 | 87 −10% |
| EBITDA | 6 | 8 | 8 | 8 | 10 +67% |
| Net profit | 3 | 3 | 3 | 3 | 4 +33% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +37.4% 1Y
1Y: ₹60.4 on 10 Sept 2025 → ₹83. High ₹91.5 (28 Aug 2026), low ₹41 (27 Mar 2026).
Balance sheet
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Equity capital | ₹12 Cr | ₹17 Cr | ₹17 Cr | ₹17 Cr |
| Reserves | ₹29 Cr | ₹55 Cr | ₹63 Cr | ₹67 Cr |
| Borrowings | ₹27 Cr | ₹35 Cr | ₹58 Cr | ₹57 Cr |
| Other liabilities | ₹34 Cr | ₹73 Cr | ₹81 Cr | ₹67 Cr |
| Total liabilities | ₹102 Cr | ₹180 Cr | ₹220 Cr | ₹208 Cr |
| Fixed assets | ₹16 Cr | ₹39 Cr | ₹30 Cr | ₹30 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹3 Cr | ₹1 Cr |
| Other assets | ₹86 Cr | ₹141 Cr | ₹187 Cr | ₹177 Cr |
| Total assets | ₹102 Cr | ₹180 Cr | ₹220 Cr | ₹208 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Mar 2026
The ownership split has held steady since Mar 2025. The shareholder count shrank 28% to 1,060.
- Promoters
- 70.0%
- Public
- 30.0%
Since Mar 2025
- Promoters 0.00 pp
- Public 0.00 pp
How it drifted, 6 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 70.0%, Public 30.0%.Mar '24: Promoters 70.0%, Public 30.0%.Sep '24: Promoters 70.0%, Public 30.0%.Mar '25: Promoters 70.0%, Public 30.0%.Sep '25: Promoters 70.0%, Public 30.0%.Mar '26: Promoters 70.0%, Public 30.0%.
Who bought this quarter
since Sep 2025
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- A1 Management And Consultancy newly disclosed 1.73% held
- Tejal Parag Dattani +0.67 pp 4.03% held
The same filing shows 0 holders trimming and 1 off the list — both are in the register beside this.
Who is on the register
Named in the Mar 2026 filing
Every holder of Crop Life Science Limited above SEBI's 1% disclosure line, and what changed since Sep 2025.
| Holder | Stake | Change |
|---|---|---|
| Rajeshkumar Vrajlal Lunagariya | 35.66% | unchanged |
| Ashwin Ravjibhai Lunagaria | 15.68% | unchanged |
| Vijayaben A Lunagaria | 9.84% | unchanged |
| Sumitaben Rajeshkumar Lunagariya | 6.16% | unchanged |
| Tejal Parag Dattani | 4.03% | +0.67 pp |
| Ravjibhai Virjibhai Lunagariya | 2.31% | unchanged |
| A1 Management And Consultancy | 1.73% | newly disclosed |
| Bansil Rajeshkumar Lunagariya | 0.18% | unchanged |
| Lunagariya Swati Ashvinbhai | 0.09% | unchanged |
| Lunagariya Rajan Ashvinbhai | 0.09% | unchanged |
| Vaibhav Equisec Private Limited | — | off the list |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
- Growth the price implies
- 2.9% a year
- for 7 years, fading to 4%
- It has actually compounded at
- Not enough history
- The gap
- —
- between what it did and what it must do
Learn to analyse Crop Life Science Limited
Guides on how to read this kind of business and the numbers that matter.